Menu
Federal Contractor Misconduct Database (FCMD)
The federal government routinely awards contracts to companies with
histories of misconduct, including
…
contract fraud and other
violations. POGO believes that providing this website will help to
improve contracting decisions and increase public knowledge of how
the government spends billions of taxpayer dollars each year.
Read more…
Off-Label Promotion of Trileptal (Criminal Prosecution)
Novartis Pharmaceuticals Corporation (NPC) pleaded guilty to a misdemeanor violation of the Federal Food, Drug and Cosmetic Act and agreed to pay a $185 million fine related to the company’s off-label promotion of the epilepsy drug Trileptal. Novartis also resolved civil claims related to the marketing of Trileptal. (See Novartis AG instance, “Off-Label Promotion of Trileptal (Civil Litigation)”)
- Misconduct Type
- Health
- Enforcement Agency
- Health and Human Services
- Contracting Party
- None
- Court Type
- Criminal
- Disposition
- Pleaded Guilty
- Date of Announcement
- 1/26/2010
| Contractors Involved |
Penalty |
| Total |
|
| Novartis AG |
$185,000,000
|
